
Pharma Reps Urge AI Boost
At China's two sessions, pharma leaders like Sun Piaoyang highlight innovative drug hospital access issues and advocate AI integration in R&D, primary care, TCM, and obesity management. Suggestions include subsidies for AI doctor assistants and AI-driven breakthroughs in key technologies. This aims to enhance innovation conversion and grassroots healthcare.






